XML 39 R28.htm IDEA: XBRL DOCUMENT v3.24.3
STOCKHOLDERS’ EQUITY AND STOCK-BASED COMPENSATION (Tables)
9 Months Ended
Sep. 28, 2024
Equity [Abstract]  
SCHEDULE OF NON-VESTED RESTRICTED STOCK ACTIVITY

Restricted stock activity for the nine month period ended September 28, 2024 was as follows:

 

  Shares   Weighted
Average Grant
Fair Value
 
Balance, December 30, 2023   1,931,767   $1.65 
Granted   4,226,320    1.30 
Forfeited   (399,644)   2.50 
Vested   (247,529)   2.00 
Balance, September 28, 2024   5,510,914    1.30 
SCHEDULE OF STOCK-BASED COMPENSATION EXPENSE

The following table summarizes stock-based compensation expense within each of the categories below as it relates to non-vested restricted common stock awards for the three and nine months ended September 28, 2024 and September 30, 2023 (no tax benefits were recognized):

 

   Three Months
Ended
   Three Months
Ended
   Nine months
ended
   Nine months
ended
 
   September 28, 2024   September 30, 2023   September 28, 2024   September 30, 2023 
Cost of product revenues  $368,312   $311,455   $857,236   $764,996 
Research and development   308,792    214,320    569,701    553,488 
Selling, general and administrative   535,842    432,560    1,197,355    1,025,298 
Total  $1,212,946   $958,335   $2,624,292   $2,343,782